Abstracts tagged "Classification criteria and fibromyalgia"

Abstract Number: 1061 • 2015 ACR/ARHP Annual Meeting
Patients with Fibromyalgia (FM) Do Not Fulfill Classification Criteria for Axial Spondyloarthritis (axSpA) but Patients with Axspa May Fulfill Classification Criteria for FM
Xenofon Baraliakos¹, Andrea Regel¹, Uta Kiltz¹, Hans-Jürgen Menne², Friedrich Dybowski³, Manfred Igelmann⁴, Ludwig Kalthoff³, Dietmar Krause⁵, Ertan Saracbasi¹, Elmar Schmitz-Bortz⁶ and Jürgen Braun¹, ¹Rheumazentrum Ruhrgebiet, Herne, Germany, ²Rheumatology practice, Dortmund, Germany, ³Private rheumatology office, Herne, Germany, ⁴Private Rheumatology office, Bochum, Germany, ⁵Internistische und rheumatologische Gemeinschaftspraxis, Gladbeck, Germany, ⁶Rheumatology practice, Hattingen, Germany
Background/Purpose: Both patients with axial spondyloarthritis (axSpA) and patients with fibromyalgia (FM) are suffering from pain. The new ASAS classification criteria for axSpA have been…
Abstract Number: 2078 • 2014 ACR/ARHP Annual Meeting
A Proposed Simple 3-Variable Index for Identification of Fibromyalgia, Analogous to Classification Criteria for RA and SLE
Sung-Hoon Park¹, Jung-Yoon Choe², Seong-Kyu Kim³, Hwajeong Lee⁴ and Theodore Pincus⁵, ¹Internal Medicine, Arthritis and Autoimmunity Research Center, Catholic University of Daegu School of Medicine, Daegu, South Korea, ²Division of Rheumatology, Catholic University of Daegu School of Medicine, Daegu, South Korea, ³Devision of Rheumatology, Department of Internal Medicine, Arthritis & Autoimmunity Research Center, Catholic University of Daegu School of Medicine, Daegu, South Korea, ⁴Internal medicine, Catholin university of Daegu School of medicine, Daegu, South Korea, ⁵rheumatology, Rush univeristy medical center, Chiacago, IL
Background/Purpose : A cumulative index that includes various quantitative data has been useful in developing classification criteria for various rheumatic diseases, including rheumatoid arthritis (RA)1…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].